Browsing Oncology

GM-CSF and Prostaglandin E1 as a New Drug Combination for Stabilization Remission after Therapy of Acute Myeloid Leukemia (AML)Published Date: 28 Apr 2016
Contact: Detlef Eric Hinz
Integrated Microfluidic Histology Chip: Biomarker Detection for Early Cancer DiagnosisPublished Date: 1 Feb 2016
Contact: Kurt Moore
ANXA9: A Therapeutic Target and Predictive Marker for Early Detection of Aggressive Breast CancerPublished Date: 22 Oct 2015
Contact: Ha Nguyen
Novel Methods for Inhibiting Angiogenesis: Phase I Clinical Trial of the Anti-Parasitic Compound, OltiprazPublished Date: 10 Oct 2015
Contact: Clarissa Ceruti, PhD, MBA
Phase I Clinical Development of V158411 for the Treatment of Advanced Cancer Published Date: 7 Oct 2015
Contact: Nerida Scott
Phase II Clinical Development of Liposomal Grb-2 for the Treatment of Haematological Cancers Published Date: 30 Sep 2015
Contact: Peter Nielsen
Development of Liposomal Bcl-2 for the Treatment of Follicular Lymphoma Published Date: 30 Sep 2015
Contact: Peter Nielsen
Phase III Clinical Development of the Prophage Series Vaccines: The Potential for Turning Tumours into Promising TreatmentsPublished Date: 31 Jul 2015
Contact: Ernest Wong
Embryonic and Adult Stem Cells Encapsulation for Cell Based Therapy and CancerPublished Date: 18 May 2015
Contact: Michael Datel
Development of a Cancer Diagnostic Probe: Portable and Disposable Hand-Held Cancer Diagnostic Device Published Date: 14 May 2015
Contact: Technion Technology Transfer
Phase II Clinical Development of CAM2032 (Prosenze®) for the Treatment of Prostate CancerPublished Date: 10 Mar 2015
Contact: Fredrik Tiberg
Nucleic Acid Encoding Fluorescent Protein Constructs and Methods for Detecting ApoptosisPublished Date: 10 Feb 2015
Contact: Shirley Woo
Phase 1-2 Clinical Development of SGI110: A DNMT Inhibitor for the Treatment of MDS, AML, Ovarian, Liver and Colorectal CancerPublished Date: 14 Jan 2015
Contact: Jeremy Carmichael
Clinical Development of ASTX727: A Novel Oral Hypomethylating Agent (HMA) for the Treatment of MDSPublished Date: 14 Jan 2015
Contact: Jeremy Carmichael
Phase 2 Clinical Development of AT13387: A Small Molecule Inhibitor of HSP90 for the Treatment of Multiple Solid Tumours and Haematological MalignanciesPublished Date: 24 Jun 2014
Contact: Jeremy Carmichael